Tag: U.S. Food and Drug Administration
New Alzheimer’s Drug Approval Could Change the FDA’s Approval Process for the Better
Raymond J. March  •  Thursday, June 10, 2021
AstraZeneca Vaccine Controversy Provides Another Example of Overly Cautious Government Reactions
Raymond J. March  •  Friday, March 26, 2021
New COVID-19 Vaccines, Same Sluggish FDA
Raymond J. March  •  Tuesday, December 15, 2020
FDA Acknowledges Coronavirus Is Causing More Drug Shortages
Raymond J. March  •  Friday, March 6, 2020
FDA’s Approval of Generic Daraprim Offers Lessons on Drugs Prices
Raymond J. March  •  Thursday, March 5, 2020
FDA Expands Ecstasy Access to Veterans with PTSD
Raymond J. March  •  Wednesday, February 12, 2020
As Insulin Prices Rise, Diabetics Turn to Black Markets
Raymond J. March  •  Tuesday, July 9, 2019
FDA To Stop Regulating the Amount of Cherries in Frozen Cherry Pie
Raymond J. March  •  Wednesday, May 15, 2019
Political Rhetoric Against Right-to-Try Laws Continues, Undermining Support for Medical Treatments of Last Resort
Raymond J. March  •  Tuesday, May 7, 2019
FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression
Raymond J. March  •  Thursday, March 28, 2019
FDA Wants More Sunscreen Regulations, but Would Consumers Get Burned?
Raymond J. March  •  Thursday, March 14, 2019
FDA Panel Backs Ketamine-Based Treatment for Depression
Raymond J. March  •  Wednesday, February 27, 2019
FDA Considers Regulating E-cigarette Juices
Raymond J. March  •  Saturday, September 1, 2018
FDA Restricts Sale of Contraceptive Device
Raymond J. March  •  Wednesday, April 18, 2018
The Decline in R&D Efficiency in the Drug Industry
Lawrence J. McQuillan  •  Tuesday, August 25, 2015
  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621-1428 | (510) 632-1366 | (510) 568-6040 FAX | SEND EMAIL